According to Galmed Pharmaceuticals
's latest financial reports the company has โฌ15.95 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | โฌ11.43 M | -11.01% |
2022-12-31 | โฌ12.85 M | -58.2% |
2021-12-31 | โฌ30.74 M | -25.69% |
2020-12-31 | โฌ41.37 M | -38.61% |
2019-12-31 | โฌ67.38 M | -14.52% |
2018-12-31 | โฌ78.83 M | 397.93% |
2017-12-31 | โฌ15.83 M | 7.8% |
2016-12-31 | โฌ14.68 M | -30.18% |
2015-12-31 | โฌ21.03 M | -20.01% |
2014-12-31 | โฌ26.29 M | 26411.12% |
2013-12-31 | โฌ0.09 M | -81.72% |
2012-12-31 | โฌ0.54 M |